AbbVie Urges Talks With Shire, May Have To Raise Bid To $51 Billion

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AbbVie Inc. (ABBV), which was rejected on three different takeover offers for Shire Plc (SHP), may have to raise its bid to about 30 billion pounds ($51 billion) to persuade the drugmaker’s board to sell.

A proposal of about 51 pounds a share would do the trick, according to the average estimate of five analysts compiled by Bloomberg News. AbbVie’s latest cash-and-stock offer valued Shire at about 27.3 billion pounds.

Help employers find you! Check out all the jobs and post your resume.

Back to news